Amina Abdeddaim
Overview
Explore the profile of Amina Abdeddaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vergori A, Del Duca G, Borrelli P, Brita A, Pinnetti C, Mastrorosa I, et al.
Heliyon
. 2024 Oct;
10(20):e39431.
PMID: 39469684
Background: We aim to investigate the proportion of patients (pts) with long-term cognitive outcomes (CO) of PACC and identify associated features. Methods: We assessed participants through a neuropsychological assessment. The...
2.
Mastrorosa I, Del Duca G, Pinnetti C, Lorenzini P, Vergori A, Brita A, et al.
Health Qual Life Outcomes
. 2023 Mar;
21(1):28.
PMID: 36949439
Background: After the acute phase, symptoms or sequelae related to post-COVID-19 syndrome may persist for months. In a population of patients, previously hospitalized and not, followed up to 12 months...
3.
Gagliardini R, Cozzi-Lepri A, Mariano A, Taglietti F, Vergori A, Abdeddaim A, et al.
Front Pharmacol
. 2021 May;
12:621676.
PMID: 33967755
No specific treatment has been approved for COVID-19. Lopinavir/ritonavir (LPV/r) and hydroxychloroquine (HCQ) have been used with poor results, and a trial showed advantages of combined antiviral therapy vs. single...
4.
Lorenzini P, Di Gennaro F, Girardi E, Abbonizio M, Abdeddaim A, Agostini E, et al.
Int J Infect Dis
. 2021 Mar;
105:532-539.
PMID: 33676001
Background: Limited data are available about the predictors and outcomes associated with prolonged SARS-CoV-2 RNA shedding (VS). Methods: A retrospective study including COVID-19 patients admitted to an Italian hospital between...
5.
Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, et al.
Nutr Metab Cardiovasc Dis
. 2020 Sep;
30(11):1899-1913.
PMID: 32912793
Background And Aims: There is poor knowledge on characteristics, comorbidities and laboratory measures associated with risk for adverse outcomes and in-hospital mortality in European Countries. We aimed at identifying baseline...
6.
Mariano A, Pisapia R, Abdeddaim A, Taibi C, Rianda A, Vincenzi L, et al.
Infez Med
. 2015 Sep;
23(3):275-9.
PMID: 26397300
Body piercing is a social phenomenon on the rise especially among young people. This procedure may be complicated by serious bacterial and viral infections. We report a case of Staphylococcus...
7.
Pisapia R, Abdeddaim A, Mariano A, Rianda A, Vincenzi L, Taibi C, et al.
Am J Ther
. 2013 Jul;
22(1):e8-e13.
PMID: 23846525
Drug-induced hepatotoxicity is a common cause of acute hepatitis, and the recognition of the responsible drug may be difficult. We describe a case of clopidogrel-related acute hepatitis. The diagnosis is...
8.
Pisapia R, Rianda A, Mariano A, Testa A, Galgani S, Vincenzi L, et al.
BMC Infect Dis
. 2013 Mar;
13:138.
PMID: 23497310
Background: Involvement of trochlear nerve during Varicella Zoster Virus (VZV) Infection has been rarely described, and always in association with skin rash. Case Presentation: We describe the case of a...
9.
Poccia F, Gioia C, Martini F, Sacchi A, Piacentini P, Tempestilli M, et al.
AIDS
. 2009 Feb;
23(5):555-65.
PMID: 19238075
Objective: gammadelta T cells bearing the Vgamma9Vdelta2 T-cell receptor exert many antiviral effector functions in humans, including release of anti-HIV factors and direct cytotoxicity against virus-infected cells. Moreover, they are...
10.
Dianzani F, Rozera G, Abbate I, DOffizi G, Abdeddaim A, Vlassi C, et al.
J Interferon Cytokine Res
. 2008 Mar;
28(1):1-3.
PMID: 18370866
In the pre-highly active antiretroviral therapy (HAART) era, clinical trials showed that interferon (IFN) treatment was able to delay AIDS progression and prolong survival. Along with HAART, ancillary use of...